Current pharmacological options for diabetes treatment help patients control blood glucose levels but do not reverse the decline in insulin-secreting β-cells. A new study now shows that a pharmacological combination of insulin and a GLP-1–oestrogen conjugate not only decreases daily insulin requirements but also improves β-cell function.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Weir, G. C. & Bonner-Weir, S. Diabetes 53(Suppl. 3), S16–S21 (2004).
Banting, F. G. & Best, C. H. J. Lab. Clin. Med. 7, 251–266 (1922).
De Jesus, D. F. & Kulkarni, R. N. Mol. Metab. 27S, S42–S48 (2019).
Talchai, C., Xuan, S., Lin, H. V., Sussel, L. & Accili, D. Cell 150, 1223–1234 (2012).
Rui, J. et al. Cell Metab. 25, 727–738 (2017).
Dirice, E. et al. Nat. Metab. 1, 509–518 (2019).
Sachs, S. Nat. Metab. https://doi.org/10.1038/s42255-020-0171-3 (2020).
Like, A. A. & Rossini, A. A. Science 193, 415–417 (1976).
Kulkarni, R. N. et al. Cell 96, 329–339 (1999).
Le May, C. et al. Proc. Natl Acad. Sci. USA 103, 9232–9237 (2006).
Drucker, D. J., Philippe, J., Mojsov, S., Chick, W. L. & Habener, J. F. Proc. Natl Acad. Sci. USA 84, 3434–3438 (1987).
Finan, B. et al. Nat. Med. 18, 1847–1856 (2012).
Bader, E. et al. Nature 535, 430–434 (2016).
Karakose, E., Ackeifi, C., Wang, P. & Stewart, A. F. Diabetologia 61, 1693–1699 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
De Jesus, D.F., Kulkarni, R.N. More is better: combinatorial therapy to restore β-cell function in diabetes. Nat Metab 2, 130–131 (2020). https://doi.org/10.1038/s42255-020-0176-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-020-0176-y
This article is cited by
-
Neue Ansätze zur Regeneration der insulinproduzierenden β-Zelle
Die Diabetologie (2022)